5 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp08317 | Sample Peptide 2 from US011339203B2 | FIGNLALSDLLAGVAYTANLLLKKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 assay | CAKI-2 | Renal Cancer | Cell Viability = 0.4% at 25 μM |
| dbacp08318 | Sample Peptide 2 from US011339203B2 | FIGNLALSDLLAGVAYTANLLLKKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 assay | PC-3 | Prostate Cancer | Cell Viability = 2.5% at 25 μM |
| dbacp08319 | Sample Peptide 2 from US011339203B2 | FIGNLALSDLLAGVAYTANLLLKKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 assay | A-2058 | Skin Cancer | Cell Viability = 0.2% at 25 μM |
| dbacp08320 | Sample Peptide 2 from US011339203B2 | FIGNLALSDLLAGVAYTANLLLKKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 assay | NCI-H2444 | Lung Cancer | Cell Viability = 0.6% at 25 μM |
| dbacp08321 | Sample Peptide 2 from US011339203B2 | FIGNLALSDLLAGVAYTANLLLKKRTLRKNDRKKR | Synthetic | Not Available | CCK-8 assay | A-549 | Lung Cancer | Cell Viability = 1.4% at 25 μM |